234
-4.10%
Close of 9 Nov 2026, in IDR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in IDR, from our data supplier.
Net income
IDR 14.54bn
FY2016FY2025
Free cash flow
−IDR 3.98bn
FY2016FY2025
Shareholders' equity
IDR 694.45bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating income | IDR 15.48bn | IDR 11.48bn | IDR 18.75bn | IDR 21.18bn | IDR 22.63bn | IDR 13.59bn | IDR 24.88bn | IDR 18.05bn | IDR 13.29bn | IDR 306.76bn |
| Net income | IDR 14.54bn | IDR 10.37bn | IDR 17.36bn | IDR 17.29bn | IDR 8.56bn | −IDR 1.48bn | IDR 2.72bn | IDR 5.92bn | IDR 8.83bn | IDR 250.75bn |
| Diluted earnings per share | 2.27 | 1.62 | 5.43 | 2.70 | 3.15 | -0.47 | 1.00 | 2.17 | 3.25 | 92.16 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | IDR 758.61bn | IDR 777.31bn | IDR 782.34bn | IDR 752.87bn | IDR 869.03bn | IDR 870.71bn | IDR 891.87bn | IDR 940.96bn | IDR 801.48bn | IDR 771.55bn |
| Cash and short-term investments | IDR 1.59bn | IDR 1.97bn | IDR 1.61bn | IDR 1.96bn | IDR 7.98bn | IDR 2.02bn | IDR 45.80bn | IDR 43.37bn | IDR 2.78bn | IDR 3.23bn |
| Total liabilities | IDR 63.87bn | IDR 97.65bn | IDR 113.02bn | IDR 100.87bn | IDR 233.33bn | IDR 245.52bn | IDR 264.40bn | IDR 265.46bn | IDR 119.59bn | IDR 98.84bn |
| Debt | IDR 50.46bn | IDR 61.03bn | IDR 70.19bn | IDR 60.65bn | IDR 184.35bn | IDR 191.40bn | IDR 202.88bn | IDR 210.26bn | IDR 82.96bn | IDR 40.11bn |
| Shareholders' equity | IDR 694.45bn | IDR 679.38bn | IDR 669.03bn | IDR 651.71bn | IDR 635.41bn | IDR 624.90bn | IDR 627.18bn | IDR 622.98bn | IDR 614.12bn | IDR 604.81bn |
| Shares outstanding | 6,400m | 6,400m | 3,200m | 6,400m | 2,721m | 3,121m | 2,721m | 2,721m | 2,721m | 2,721m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | −IDR 3.98bn | IDR 9.54bn | IDR 21.23bn | IDR 9.17bn | IDR 15.37bn | −IDR 11.43bn | IDR 14.59bn | IDR 32.02bn | IDR 12.18bn | IDR 271.81bn |
| Capital spending | −IDR 1.6m | −IDR 950,000 | −IDR 1.05bn | −IDR 308.8m | −IDR 156.6m | −IDR 4.13bn | −IDR 286.4m | −IDR 23.45bn | −IDR 40.69bn | — |
| Free cash flow | −IDR 3.98bn | IDR 9.54bn | IDR 20.18bn | IDR 8.86bn | IDR 15.21bn | −IDR 15.56bn | IDR 14.30bn | IDR 8.57bn | −IDR 28.51bn | IDR 271.81bn |
| Dividends paid | — | — | — | — | — | — | — | −IDR 14.57bn | — | — |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Operating income | IDR 818.3m | −IDR 1.99bn | −IDR 717.0m | −IDR 1.86bn | −IDR 2.41bn | IDR 20.69bn | IDR 8.55bn | −IDR 801.3m |
| Net income | IDR 627.4m | −IDR 1.93bn | −IDR 865.4m | −IDR 1.92bn | −IDR 2.54bn | IDR 19.86bn | IDR 7.99bn | −IDR 886.4m |
| Diluted earnings per share | 0.10 | -0.30 | -0.14 | -0.30 | -0.40 | 3.10 | 1.25 | -0.14 |
| Cash from operations | −IDR 2.72bn | −IDR 3.21bn | −IDR 4.37bn | −IDR 4.08bn | IDR 2.02bn | IDR 2.45bn | IDR 2.14bn | IDR 5.05bn |
| Capital spending | — | −IDR 2.0m | — | −IDR 1.0m | −IDR 1.0m | −IDR 1.0m | — | — |
| Free cash flow | — | −IDR 3.21bn | — | −IDR 4.08bn | IDR 2.02bn | IDR 2.45bn | — | — |
| Total assets | IDR 747.48bn | IDR 754.89bn | IDR 758.61bn | IDR 762.90bn | IDR 767.35bn | IDR 773.18bn | IDR 777.31bn | IDR 777.38bn |
| Cash and short-term investments | IDR 1.60bn | IDR 1.61bn | IDR 1.59bn | IDR 1.41bn | IDR 1.41bn | IDR 1.80bn | IDR 1.97bn | IDR 2.91bn |
| Debt | IDR 45.14bn | IDR 47.90bn | IDR 50.46bn | IDR 53.18bn | IDR 55.85bn | IDR 58.34bn | IDR 61.03bn | IDR 63.23bn |
| Shareholders' equity | IDR 693.15bn | IDR 692.53bn | IDR 694.45bn | IDR 694.78bn | IDR 696.70bn | IDR 699.23bn | IDR 679.38bn | IDR 671.41bn |
Financial ratios
Data as of 27 Aug 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Operating margin | 48.3% | 32.5% | 44.0% | 40.4% | 42.9% | 26.5% |
| Net margin | 45.4% | 29.3% | 40.8% | 33.0% | 16.2% | -2.9% |
| Return on equity | 2.1% | 1.5% | 2.6% | 2.7% | 1.3% | -0.2% |
| Return on assets | 1.9% | 1.3% | 2.2% | 2.3% | 1.0% | -0.2% |
| Free cash flow yield | -0.2% | 0.6% | 2.7% | 0.6% | 2.2% | -0.9% |
| Revenue growth | -9.3% | -17.1% | -18.7% | -0.7% | 2.8% | -39.1% |
| Earnings growth | 40.3% | -40.3% | 0.4% | 102.1% | -677.6% | -154.5% |
| Current ratio | 2.73x | 2.10x | 2.06x | 2.85x | 1.28x | 3.27x |
| Debt to equity | 0.07x | 0.09x | 0.10x | 0.09x | 0.29x | 0.31x |
| Equity ratio | 91.5% | 87.4% | 85.5% | 86.6% | 73.1% | 71.8% |
| Interest coverage | 40.86x | 136.79x | 118.96x | 5.09x | 1.38x | 0.81x |
| Buybacks as a share of market value | 0.0% | -100.0% | 50.0% | -135.2% | 12.8% | -14.7% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | -15.1% | -9.0% | -18.2% |
| Operating income | -9.9% | 2.6% | -22.0% |
| Net income | -5.6% | — | -15.9% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Operating margin | 40.0% | 41.2% | 38.7% | 60.9% |
| Net margin | 37.0% | 36.7% | 25.0% | 39.0% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 130.3 | 336.5 | 59.0 | 40.3 | 51.4 | -600.0 | 200.0 | 136.9 | 67.4 | 2.3 |
| Price to sales | 59.1 | 98.8 | 24.1 | 13.3 | 8.3 | 17.3 | 6.5 | 18.7 | 16.9 | 1.4 |
Dividends and splits
Per share, in the currency the company pays
Paid for 0 years. Last went ex-dividend on 28 Jun 2001.
| FY2001 | |
|---|---|
| Paid in the year | 1.70 |
- 2.051-for-1 split · 7 Nov 2023
- 1.147-for-1 split · 7 Jul 2023
- 5-for-1 split · 2 Jul 2002
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.